Literature DB >> 24527959

Low-level laser therapy improves vision in a patient with retinitis pigmentosa.

Boris T Ivandic1, Tomislav Ivandic.   

Abstract

OBJECTIVE: This case report describes the effects of low-level laser therapy (LLLT) in a single patient with retinitis pigmentosa (RP). BACKGROUND DATA: RP is a heritable disorder of the retina, which eventually leads to blindness. No therapy is currently available.
METHODS: LLLT was applied using a continuous wave laser diode (780 nm, 10 mW average output at 292 Hz, 50% pulse modulation). The complete retina of eyes was irradiated through the conjunctiva for 40 sec (0.4 J, 0.333 W/cm2) two times per week for 2 weeks (1.6 J). A 55-year-old male patient with advanced RP was treated and followed for 7 years.
RESULTS: The patient had complained of nyctalopia and decreasing vision. At first presentation, best visual acuity was 20/50 in each eye. Visual fields were reduced to a central residual of 5 degrees. Tritan-dyschromatopsy was found. Retinal potential was absent in electroretinography. Biomicroscopy showed optic nerve atrophy, and narrow retinal vessels with a typical pattern of retinal pigmentation. After four initial treatments of LLLT, visual acuity increased to 20/20 in each eye. Visual fields normalized except for a mid-peripheral absolute concentric scotoma. Five years after discontinuation of LLLT, a relapse was observed. LLLT was repeated (another four treatments) and restored the initial success. During the next 2 years, 17 additional treatments were performed on an "as needed" basis, to maintain the result.
CONCLUSIONS: LLLT was shown to improve and maintain vision in a patient with RP, and may thereby have contributed to slowing down blindness.

Entities:  

Mesh:

Year:  2014        PMID: 24527959     DOI: 10.1089/pho.2013.3535

Source DB:  PubMed          Journal:  Photomed Laser Surg        ISSN: 1549-5418            Impact factor:   2.796


  6 in total

1.  Variability and Errors of Manually Digitized Goldmann Visual Fields.

Authors:  Michael P Barry; Ava K Bittner; Liancheng Yang; Rebecca Marcus; Mian Haris Iftikhar; Gislin Dagnelie
Journal:  Optom Vis Sci       Date:  2016-07       Impact factor: 1.973

Review 2.  Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy.

Authors:  David J Ramsey; G B Arden
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

Review 3.  Photobiomodulation for the treatment of retinal diseases: a review.

Authors:  Ivayla I Geneva
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

4.  A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION.

Authors:  Samuel N Markowitz; Robert G Devenyi; Marion R Munk; Cindy L Croissant; Stephanie E Tedford; Rene Rückert; Michael G Walker; Beatriz E Patino; Lina Chen; Monica Nido; Clark E Tedford
Journal:  Retina       Date:  2020-08       Impact factor: 3.975

5.  Analysis of Retinal Layers' Thickness and Vascular Density after Successful Scleral Buckle Surgery.

Authors:  Narges Hassanpoor; Amir Eftekhari Milani; Alireza Kordestani; Mohamad Reza Niyousha
Journal:  J Curr Ophthalmol       Date:  2021-10-22

6.  Effects of Photo-Biomodulation in Stargardt Disease.

Authors:  Sergio Zaccaria Scalinci; Nicola Valsecchi; Elena Pacella; Edoardo Trovato Battagliola
Journal:  Clin Ophthalmol       Date:  2022-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.